|
|
|
|
| LEADER |
01149nam a22003131 4500 |
| 001 |
c000138344 |
| 003 |
CARM |
| 005 |
00000000000000.0 |
| 008 |
710421s1967 enk b 00010 eng b |
| 015 |
|
|
|a B68-03014
|
| 019 |
1 |
|
|a 16880
|z 4609790
|5 LACONCORD2021
|
| 035 |
|
|
|a (OCoLC)455765
|5 LACONCORD2021
|
| 050 |
|
|
|a RC271.C5
|b T5
|
| 060 |
|
|
|a QZ 267 T584c 1967
|
| 100 |
1 |
|
|a Timmis, G. M.
|
| 245 |
1 |
0 |
|a Chemotherapy of cancer: the antimetabolite approach
|c [by] G. M. Timmis and D. C. Williams.
|
| 260 |
|
|
|a London,
|b Butterworths,
|c 1967.
|
| 300 |
|
|
|a xii, 229 p.
|c 22 cm.
|
| 440 |
|
0 |
|a Cancer monograph series
|
| 504 |
|
|
|a Bibliography: p. 195-221.
|
| 650 |
|
0 |
|a Antimetabolites.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
| 650 |
|
2 |
|a Antimetabolites
|x therapeutic use.
|
| 650 |
|
2 |
|a Antineoplastic agents
|x Therapeutic use.
|
| 700 |
1 |
|
|a Williams, Donald Charles,
|e joint author.
|
| 852 |
8 |
|
|b CARM
|h A2:AD30G0
|i B00057
|p 0002207
|f BK
|
| 082 |
0 |
4 |
|a 616.9/94/061
|
| 999 |
f |
f |
|i c5eb66e1-8c42-578e-b972-4d3a77164145
|s e5890545-8da0-57c8-ba67-c3a45fd64b03
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|e B00057
|f A2:AD30G0
|h Other scheme
|i book
|m 0002207
|